EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation

Patience Chihomvu, A Ganesan iD, Simon Gibbons, Kevin Woollard, Martin A Hayes

International Journal of Molecular Sciences · 13.08.2024 · 25 (16) · 8792

DOI: 10.3390/ijms25168792 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.08.2024. Verfasst von Patience Chihomvu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden. Hauptthemen laut MEDLINE: Phytochemicals, Drug Discovery, Quantitative Structure-Activity Relationship. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca Postdoctoral Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products’ potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. An emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsDrug DiscoveryQuantitative Structure-Activity RelationshipHumansMachine LearningMolecular Docking SimulationBiological Products

Stichwörter der Autor:innen

natural productsphytochemicalstraditional medicine

Substanzen

PhytochemicalsBiological Products

Autor:innen und Institutionen

  • Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden.
  • School of Chemistry, Pharmacy & Pharmacology, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
  • Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mawz 616, Oman.
  • Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB21 6GH, UK.

ORCID-Profile: A Ganesan

Förderung

  • AstraZeneca Postdoctoral Program

Zitieren

APA

Chihomvu, P., Ganesan, A., Gibbons, S., Woollard, K., & Hayes, M. A. (2024). Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation. International Journal of Molecular Sciences, 25(16), 8792. https://doi.org/10.3390/ijms25168792

Vancouver

Chihomvu P, Ganesan A, Gibbons S, Woollard K, Hayes MA. Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation. International Journal of Molecular Sciences. 2024;25(16):8792. doi:10.3390/ijms25168792

BibTeX
@article{Chihomvu2024,
  author = {Chihomvu, Patience and Ganesan, A and Gibbons, Simon and Woollard, Kevin and Hayes, Martin A},
  title = {Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {16},
  pages = {8792},
  doi = {10.3390/ijms25168792}
}
Kostenlos starten →